基于唾液微小RNA特征诊断子宫内膜异位症相关不孕症
前瞻性ENDOmiARN研究(NCT04728152)纳入200例有盆腔痛提示子宫内膜异位症的女性,于2021年1月至6月采集唾液样本,经腹腔镜和/或磁共振成像诊断。153例确诊子宫内膜异位症者中24%(n=36)不孕、76%(n=117)生育力正常;通过小RNA测序和随机森林模型构建34个miRNA的唾液特征,验证后模型灵敏度、特异度和曲线下面积均为100%。
要点
- 前瞻性ENDOmiARN研究纳入200例盆腔痛女性,153例确诊子宫内膜异位症。
- 确诊者中24%(n=36)不孕,76%(n=117)生育力正常。
- 基于34个miRNA的唾液特征模型验证后灵敏度、特异度、AUC均为100%。
核心结论
- 报道了一种用于子宫内膜异位症相关不孕的唾液miRNA特征。
- 结果在常规实践使用前仍需外部验证,但这一无创工具可能对子宫内膜异位症女性的诊疗产生重大影响。
研究设计与样本
- 前瞻性ENDOmiARN研究(NCT04728152)于2021年1月至2021年6月采集200例有盆腔痛提示子宫内膜异位症女性的唾液样本。
- 所有患者接受腹腔镜、磁共振成像或两者。
- 确诊子宫内膜异位症者按生育状态分为不孕组和生育力正常组。
- 采用下一代测序鉴定miRNA生物标志物,基于随机森林模型构建唾液不孕特征。
主要发现
- 153例确诊子宫内膜异位症患者中,不孕者24%(n=36),生育力正常者76%(n=117)。
- 对153份唾液样本行小RNA测序,获得约3712 M原始测序reads(每样本约13.7 M至约39.3 M reads)。
- 在2561个已知miRNA中,特征选择方法生成34个与子宫内膜异位症相关不孕相关的miRNA特征。
- 验证后最准确的模型灵敏度、特异度和曲线下面积均为100%。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 结果在常规实践使用该特征前仍需外部验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: Can a saliva-based miRNA signature for endometriosis-associated infertility be designed and validated by analysing the human miRNome? DESIGN: The prospective ENDOmiARN study (NCT04728152) included 200 saliva samples obtained between January 2021 and June 2021 from women with pelvic pain suggestive of endometriosis. All patients underwent either laparoscopy, magnetic resonance imaging, or both. Patients diagnosed with endometriosis were allocated to one of two groups according to their fertility status. Data analysis consisted of identifying a set of miRNA biomarkers using next-generation sequencing, and development of a saliva-based miRNA signature of infertility among patients with endometriosis based on a random forest model. RESULTS: Among the 153 patients diagnosed with endometriosis, 24% (n = 36) were infertile and 76% (n = 117) were fertile. Small RNA-sequencing of the 153 saliva samples yielded approximately 3712 M raw sequencing reads (from ∼13.7 M to ∼39.3 M reads/sample). Of the 2561 known miRNAs, the feature selection method generated a signature of 34 miRNAs linked to endometriosis-associated infertility. After validation, the most accurate signature model had a sensitivity, specificity and area under the curve of 100%. CONCLUSION: A saliva-based miRNA signature for endometriosis-associated infertility is reported. Although the results still require external validation before using the signature in routine practice, this non-invasive tool is likely to have a major effect on care provided to women with endometriosis.
引用
- Dabi Y, Suisse S, Puchar A, et al. Endometriosis-associated infertility diagnosis based on saliva microRNA signatures. Reprod Biomed Online. 2022. PMID: 36411203. doi:10.1016/j.rbmo.2022.09.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。